Скачать или смотреть Mantle Cell Lymphoma - What's new?

Watch the recording of our educational webinar tailored for patients, families, and carers affected by Mantle Cell lymphoma.

Hosted by Lymphoma Australia, his session was recorded live with Professor Constantine Tam on the 21st July 2025 and provides valuable insights into Mantle Cell Lymphoma, including current management strategies, recent treatment developments, and what the future of care may look like.

Professor Constantine (Con) Tam is a leading expert in lymphoma and an internationally recognised Clinical Haematologist. He currently heads the Lymphoma Service at Alfred Health and holds a Professorship at Monash University.

Professor Tam completed his medical training at the University of Melbourne and went on to dual specialise in Haematology and Haematopathology. His training includes a Leukemia Fellowship at the world-renowned MD Anderson Cancer Centre.

Prior to his current role, he served for over a decade as the Disease Group Lead for Low Grade Lymphoma and CLL at Peter MacCallum Cancer Centre.

A pioneer in the development of targeted therapies, Professor Tam led the global development of the BTK inhibitor zanubrutinib and conducted the first international trial combining ibrutinib and venetoclax—results of which were published in the New England Journal of Medicine.

He also served as the Australian lead for the pivotal Tisagenlecleucel study, which helped establish CAR T-cell therapy as a standard treatment for diffuse large B-cell lymphoma.

With over 300 peer-reviewed publications and more than 27,000 citations, Professor Tam’s research continues to shape the future of lymphoma care worldwide. He is also an Associate Editor for Blood Advances.